Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related death, but it remains difficult to treat. Intratumor genetic and phenotypic heterogeneity are inherent properties of breast, skin, lung, prostate, and brain tumors, and intratumor heterogeneity (ITH) helps define prognosis a...
Enregistré dans:
Auteurs principaux: | Sharanya Maanasi Kalasekar, Chad H. VanSant-Webb, Kimberley J. Evason |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/40e749afbae64edf93d626e3af8de048 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
par: Andrea Angius, et autres
Publié: (2021) -
Tumor Heterogeneity and Consequences for Bladder Cancer Treatment
par: Etienne Lavallee, et autres
Publié: (2021) -
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients
par: Gedmante Radziuviene, et autres
Publié: (2021) -
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
par: Christoph Röcken, et autres
Publié: (2021) -
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
par: Gi Ru Shin, et autres
Publié: (2021)